SHI Wenjing  

  • Chief Physician, Graduate Supervisor
  • Department: Pediatrics
  • Research Area: Pediatrics
  • Research Interests: Neonatal Infection, Hyperbilirubinemia, Respiratory Distress Syndrome, Oxygen therapy
  • Contact: horse20021019@163.com
  • Resident, Fellowship, Attending, Associate Chief Physician, Chief Physician, Children's Hospital of Fudan University, 1996-2016
  • MD from Shanghai Medical Center of Fudan University, 2004
  • Director, Department of Pediatrics, Shanghai Sixth People's Hospital
  • Associated Chairman,  Division of Perinatal Medicine, Shanghai Medical Association
  1. Dai Y, Zhai G, Zhang S, Chen C, Li Z, Shi W. The clinical characteristics and serological outcomes of infants with confirmed or suspected congenital syphilis in Shanghai, China: A hospital-based study. Frontiers in Pediatrics, 2022,10:802071. doi: 10.3389/fped.2022.802071.    
  2. Mei Zeng, Wenjing Shi, Hailing Chang, Aimin Wang, Leiyan He, Pan Fu, Xuebin Xu, and Chuanqing Wang. Clonal spread of enterotoxigenic Echerichia coli O128:H45 strain in the neonate units. Jpn J Infect Dis, 2016, 69: 127–130.    
  3. Shi W, Zhu L, Wang Y, Hu B, Xiao H, Zhou G, Chen C. Estrogen therapy to treat retinopathy in newborn mice. Exp Therap Med, 2015;10(2): 611-617
  • 01/01/2010-12/31/2012
    National Natural Science Foundation of China, ¥300,000
    Preperation of Recombinant Human Pigment Epithelium-Derived Factor Peptide and its Inhibitious Factor on Abnormal Oxygen-Induced Retinal Neovascularization
    Role: Project leader